Publications

Key publications of interest relating to our science

Title Authors Journal reference Link
Selective PDE inhibitors as novel treatments for respiratory diseases. Page CP, Spina D. Curr Opin Pharmacol. 2012 Jun;12(3):275-86. doi: 10.1016/j.coph.2012.02.016. Epub 2012 Apr 11. Link
Emerging anti-inflammatory strategies for COPD. Cazzola M, Page CP, Calzetta L, Matera MG. Eur Respir J. 2012 Sep;40(3):724-41. doi: 10.1183/09031936.00213711. Epub 2012 Apr 10. Link
Effects of heparin and related drugs on neutrophil function. Brown RA, Leung E, Kankaanranta H, Moilanen E, Page CP. Pulm Pharmacol Ther. 2012 Apr;25(2):185-92. Epub 2012 Feb 4. Link
Airway responsiveness in an allergic rabbit model. Keir SD, Spina D, Douglas G, Herd C, Page CP. J Pharmacol Toxicol Methods. 2011 Sep-Oct;64(2):187-95. Epub 2011 Aug 11. Link
Pharmacological characterization of adenosine receptors on isolated human bronchi. Calzetta L, Spina D, Cazzola M, Page CP, Facciolo F, Rendina EA, Matera MG. Am J Respir Cell Mol Biol. 2011 Dec;45(6):1222-31. Epub 2011 Jun 23. Link
Phosphodiesterase inhibitors in the treatment of inflammatory diseases. Page CP, Spina D. Handb Exp Pharmacol. 2011;(204):391-414. Link
Novel bronchodilators for the treatment of chronic obstructive pulmonary disease. Matera MG, Page CP, Cazzola M. Trends Pharmacol Sci. 2011 Aug;32(8):495-506. Epub 2011 Jun 16. Link
Evaluation of the effects of the R- and S-enantiomers of salbutamol on equine isolated bronchi. Matera MG, Calzetta L, Rogliani P, Bardaro F, Page CP, Cazzola M. Pulm Pharmacol Ther. 2011 Apr;24(2):221-6. Epub 2010 Dec 31 Link
The pharmacology of novel long acting phosphodiesterase inhibitors RPL554 and RPL565. Boswell-Smith,V., Spina,D., Oxford,A., Comer,M.B., Seeds,E.A.M., Page,C.P. J.Pharmacol.Exp.Ther. 318 (2): 840-848 (2006). Link
Possible Contribution of Prostaglandin E2 to the antiproliferative effect of phosphodiesterase 4 inhibitors in human mononuclear cells. Banner, K.H., Hoult, J.R., Taylor, M.N., Landells, L.J., & Page, C.P. Biochem Pharmacol 58: 1487-1495 (1999). Link
Close

Verona Pharma plc
3 More London Riverside, London SE1 2RE
T: +44 (0)203 283 4200

Linkedin     Email Us